INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,630,000 | -15.5% | 212,401 | +3.2% | 0.01% | -29.4% |
| Q1 2021 | $4,297,000 | -8.8% | 205,812 | -0.0% | 0.02% | -19.0% |
| Q4 2020 | $4,714,000 | -28.4% | 205,830 | -49.0% | 0.02% | -43.2% |
| Q3 2020 | $6,585,000 | +88.3% | 403,744 | +56.3% | 0.04% | +68.2% |
| Q2 2020 | $3,498,000 | +58.9% | 258,362 | +99.6% | 0.02% | +46.7% |
| Q3 2019 | $2,202,000 | +74.3% | 129,428 | +302.9% | 0.02% | -6.2% |
| Q1 2018 | $1,263,000 | – | 32,127 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |